BHVI Embarks on a New Program for Growth


SYDNEY, Australia — Brien Holden Vision Institute (BHVI) announced that it is embarking on a new strategic roadmap, a process that includes realigning its organizational structure. As part of the realignment, Dr. Arthur Back has been appointed managing director of VisionCRC, BHVI’s science arm which translates the organization’s research into commercial products. "We are excited to have Dr. Arthur Back join us. Dr Back invented more than 60 patents and commercialized 18 products while he was chief technology officer at CooperVision. Combined with the expertise of Professor Sankaridurg, a pioneer in the field of Myopia research, we are at the forefront of our industry,” said Yvette Waddell, CEO of BHVI.

BHVI said in a statement that under the leadership of Dr. Back and Professor Padmaja Sankaridurg, it will continue to build “an innovative R&D organization, cementing our exceptional track record and developing sustainable, collaborative, commercial models.” BHVI also said it is building new revenue streams through the growth of its professional services business providing myopia management and education programs, globally.